ISSN 2149-2263 | E-ISSN 2149-2271
pdf
Arrhythmogenic right ventricular dysplasia: from genetics to treatment [Anatol J Cardiol]
Anatol J Cardiol. 2009; 9(Suppl 2): 24-31

Arrhythmogenic right ventricular dysplasia: from genetics to treatment

Omar E. Wevew-Pinzo1, Merle Myerson2, Mark V. Sherrid3
1Division of Cardiology St. Luke’s - Roosevelt Hospital Center Columbia University, College of Physicians & Surgeons New York City, NY, USA
2Division of Pre-Exercise Heart Screening Program St. Luke’s - Roosevelt Hospital Center Columbia University, College of Physicians & Surgeons New York City, NY, USA
3Division of Cardiology, Department of Medicine, St. Luke’s-Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, NY, USA

Arrhythmogenic right ventricular dysplasia (ARVD), also known as arrhythmogenic right ventricular cardiomyopathy, is a genetic cause for sudden cardiac arrest. In ARVD, there is progressive replacement of normal myocytes, with fat and fibrous tissue, predominantly in the right ventricle that predisposes the individual to arrhythmias. Patients who are identified with this condition are risk stratified; those at high risk are recommended to have implanted cardioverter defibrillators

Keywords: Arrhythmogenic right ventricular dysplasia, implantable cardioverter defibrillator, sudden cardiac death

Omar E. Wevew-Pinzo, Merle Myerson, Mark V. Sherrid. Arrhythmogenic right ventricular dysplasia: from genetics to treatment. Anatol J Cardiol. 2009; 9(Suppl 2): 24-31
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.